Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -41.92% is 43% above its 5-year average of -74.09%, near the high end of its 5-year range (-1308.84%–-15.17%).
As of the fiscal period ended Tuesday, June 30, 2026. 63.00% above its 12-month average of -113.28%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -41.92%.
RETURN ON INVESTED CAPITAL (ROIC)
-41.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-113.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-168.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-74.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+63.00%
CURRENT VS 3Y AVG
+75.13%
CURRENT VS 5Y AVG
+43.42%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 706 covered companies
CURRENT VS SECTOR MEDIAN
-24.71%
vs the sector median at left
HCW Biologics Inc.
Market Cap
$563178.00
Return on Invested Capital (ROIC)
-41.92%
TTM Avg
-113.28%
3Y Avg
-168.56%
5Y Avg
-74.09%
Market Cap
$669300.00
Return on Invested Capital (ROIC)
4.47%
TTM Avg
-1129.41%
3Y Avg
-780.32%
5Y Avg
-986.52%
Market Cap
$381940.00
Return on Invested Capital (ROIC)
-10.38%
TTM Avg
-17.82%
3Y Avg
-53.65%
5Y Avg
-61.91%
Market Cap
$809925.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-3.54%
3Y Avg
-13.19%
5Y Avg
-11.55%
Market Cap
$816286.00
Return on Invested Capital (ROIC)
-77.55%
TTM Avg
-118.09%
3Y Avg
-161.88%
5Y Avg
-137.96%
Market Cap
$845829.00
Return on Invested Capital (ROIC)
-343.55%
TTM Avg
-272.49%
3Y Avg
-270.70%
5Y Avg
-191.72%
Market Cap
$858810.00
Return on Invested Capital (ROIC)
-18.56%
TTM Avg
-21.38%
3Y Avg
-25.71%
5Y Avg
-46.44%
Market Cap
$859931.00
Return on Invested Capital (ROIC)
-78.01%
TTM Avg
-90.63%
3Y Avg
-141.82%
5Y Avg
-116.81%
Market Cap
$873967.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-416.12%
3Y Avg
-338.16%
5Y Avg
-243.59%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCW Biologics Inc. (HCWB) | $563178.00 | -41.92% | -113.28% | -168.56% | -74.09% |
| CDT Equity Inc. (CDT)vs › | $669300.00 | 4.47% | -1129.41% | -780.32% | -986.52% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | -10.38% | -17.82% | -53.65% | -61.91% |
| Ridgetech, Inc. (RDGT)vs › | $809925.00 | N/A | -3.54% | -13.19% | -11.55% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $816286.00 | -77.55% | -118.09% | -161.88% | -137.96% |
| Decoy Therapeutics Inc. (DCOY)vs › | $845829.00 | -343.55% | -272.49% | -270.70% | -191.72% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $858810.00 | -18.56% | -21.38% | -25.71% | -46.44% |
| Bone Biologics Corporation (BBLG)vs › | $859931.00 | -78.01% | -90.63% | -141.82% | -116.81% |
| GlucoTrack, Inc. (GCTK)vs › | $873967.00 | N/A | -416.12% | -338.16% | -243.59% |
| Psyence Biomedical Ltd. (PBM)vs › | $94810.00 | N/A | -45.65% | -31.03% | -23.30% |
ROIC
-41.9%
ROE
-66.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -41.92% |
| 2026-03-31 | -46.22% |
| 2025-12-31 | -113.51% |
| 2025-09-30 | -220.04% |
| 2025-06-30 | -144.73% |
| 2025-03-31 | -445.40% |
| 2024-12-31 | -425.86% |
| 2024-09-30 | -1308.84% |
| 2024-06-30 | -1032.92% |
| 2024-03-31 | -162.51% |
| 2023-12-31 | -130.11% |
| 2023-09-30 | -68.00% |
| 2023-06-30 | -55.81% |
| 2023-03-31 | -47.57% |
| 2022-12-31 | -34.39% |
| 2022-09-30 | -25.53% |
| 2022-06-30 | -27.23% |
| 2022-03-31 | -23.89% |
| 2021-12-31 | -26.11% |
| 2021-09-30 | -15.17% |
| 2021-06-30 | -76.84% |
| 2021-03-31 | -59.06% |
| 2020-12-31 | -38.92% |
